AU2001279643A1 - A method of treatment of alzheimer's disease with a protein extractable from mammalian organs - Google Patents

A method of treatment of alzheimer's disease with a protein extractable from mammalian organs

Info

Publication number
AU2001279643A1
AU2001279643A1 AU2001279643A AU7964301A AU2001279643A1 AU 2001279643 A1 AU2001279643 A1 AU 2001279643A1 AU 2001279643 A AU2001279643 A AU 2001279643A AU 7964301 A AU7964301 A AU 7964301A AU 2001279643 A1 AU2001279643 A1 AU 2001279643A1
Authority
AU
Australia
Prior art keywords
alzheimer
disease
treatment
mammalian organs
protein extractable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279643A
Inventor
Alberto Panerai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rakepoll Holding BV
Original Assignee
Rakepoll Holding BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding BV filed Critical Rakepoll Holding BV
Publication of AU2001279643A1 publication Critical patent/AU2001279643A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AU2001279643A 2000-06-08 2001-06-04 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs Abandoned AU2001279643A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20999800P 2000-06-08 2000-06-08
US60/209,998 2000-06-08
PCT/EP2001/006339 WO2001093896A2 (en) 2000-06-08 2001-06-04 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
AU2001279643A1 true AU2001279643A1 (en) 2001-12-17

Family

ID=22781198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279643A Abandoned AU2001279643A1 (en) 2000-06-08 2001-06-04 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs

Country Status (7)

Country Link
US (1) US20030165492A1 (en)
EP (1) EP1286688A2 (en)
JP (1) JP2003535143A (en)
AU (1) AU2001279643A1 (en)
CA (1) CA2411432A1 (en)
MX (1) MXPA02012089A (en)
WO (1) WO2001093896A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005154B2 (en) 2008-09-26 2015-04-14 Covidien Lp Valved hemodialysis catheter
US10143822B2 (en) 2012-07-05 2018-12-04 Covidien Lp Valved tip catheters
CU24626B1 (en) * 2019-12-26 2022-11-07 Centro Nac De Biopreparados PHARMACEUTICAL COMPOSITION BASED ON PROTEINS WITH NEUROPROTECTIVE, IMMUNOMODULATORY, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITIES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6660268B1 (en) * 1994-03-18 2003-12-09 The President And Fellows Of Harvard College Proteasome regulation of NF-KB activity
IT1290828B1 (en) * 1997-03-25 1998-12-11 Zetesis Spa USE OF EXTRACTABLE PROTEINS FROM ANIMAL ORGANS FOR THE PREPARATION OF MEDICATIONS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS

Also Published As

Publication number Publication date
EP1286688A2 (en) 2003-03-05
JP2003535143A (en) 2003-11-25
WO2001093896A3 (en) 2002-10-31
US20030165492A1 (en) 2003-09-04
CA2411432A1 (en) 2001-12-13
MXPA02012089A (en) 2004-08-19
WO2001093896A2 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2002223640A1 (en) Fusion proteins as immunization treatments of alzheimer's disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU2001278084A1 (en) Model for alzheimer's disease and other neurodegenerative diseases
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
AU7708498A (en) Nematode model for alzheimer's disease
AU2610901A (en) Predictive diagnostic for alzheimer's disease
AU2002363825A1 (en) Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2001273661A1 (en) Methods of screening for alzheimer's disease
AU2002246490A1 (en) Method of treating parkinson's disease
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2002302238A1 (en) A method of treatment of alzheimer's disease and device therefor
AU1405899A (en) Treatment for alzheimer's disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU2001279643A1 (en) A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
EP1181550A4 (en) Methods for the identification of compounds for the treatment of alzheimer's disease
AU2002303957A1 (en) Method of treating alzheimer's disease with se-containing peptide
AU2001262340A1 (en) A method of treatment of parkinson's disease with a protein extractable from mammalian organs
AU2001255439A1 (en) Method of treating alzheimer's disease
AU2001278436A1 (en) A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs